STRATA Skin Sciences, Inc. Stock Börse Stuttgart
Equities
E2O
US86272A3059
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 EUR | -9.38% |
|
+778.79% | +494.26% |
May. 15 | STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Sales 2024 * | 31.16M 28.63M | Sales 2025 * | 33.82M 31.08M | Capitalization | 10.17M 9.34M |
---|---|---|---|---|---|
Net income 2024 * | -10M -9.19M | Net income 2025 * | -5M -4.59M | EV / Sales 2024 * | 0.33 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-1.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on STRATA Skin Sciences, Inc.
1 week | +778.79% | ||
1 month | +701.10% | ||
3 months | +480.00% | ||
6 months | +541.59% | ||
Current year | +494.26% |
![Extreme 2.9](/images/extremecours_fleche.png)
![Extreme 2.9](/images/extremecours_fleche.png)
![Extreme 2.62](/images/extremecours_fleche.png)
![Extreme 2.62](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director of Finance/CFO | 42 | 21-07-05 | |
Shmuel Gov
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 18-05-28 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director/Board Member | 60 | 18-05-28 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.76% | 205B | |
+5.22% | 179B | |
+32.32% | 158B | |
+32.85% | 113B | |
+3.80% | 64.93B | |
+23.33% | 56.51B | |
-4.03% | 46.36B | |
-7.22% | 37.07B | |
+3.02% | 36.12B |
- Stock Market
- Equities
- SSKN Stock
- E2O Stock